Drug & supplement interaction

Haronga + Lorlatinib

Lorlatinib brand name: Lorbrena.

No Known Interaction

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated June 2026 · Pair last verified Sep 20, 2026

The bottom line No known interaction

We found no known interaction between Haronga and Lorlatinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share

Facebook Post Reddit Email

On this page

Interaction report

Haronga and Lorlatinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Lorlatinib and Haronga in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Haronga at all — not against Lorlatinib, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Haronga safety at a glance

Haronga overall Use caution Limited safety data exist, so use carefully and only when advised.

Pregnancy Avoid Not enough safety information; best avoided during pregnancy.

Breastfeeding Avoid Not enough safety information; best avoided while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Lorlatinib and Haronga? Ask Dr. Brian Staiger, PharmD, BCPS directly ›

What to actually watch for

What Lorlatinib’s Own FDA Label Lists

This is not an interaction — none of it involves Haronga. These are the most notable effects listed in the ADVERSE REACTIONS section of Lorlatinib’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

Mania or an unusually elevated mood Worth acting on
Loss of vision Worth acting on
Low magnesium Worth acting on
Thoughts of self-harm Worth acting on
Muscle weakness Worth acting on
Memory problems Worth acting on
High potassium Worth acting on
Unsteadiness Worth acting on
A heart attack Worth acting on
Blood clots Worth acting on

Showing the 10 most notable of 48 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Lorlatinib. Read the label on DailyMed › Where a percentage is shown, it is the share of 6,977 voluntary FDA FAERS reports for Lorlatinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Haronga’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Haronga side to compare — that is a limit of the record, not a statement that Haronga has no side effects.

Everything else you take

See Every Supplement That Interacts With Lorlatinib

This page covers Haronga only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Lorlatinib page lists 153 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Grapefruit (major), St. John's Wort (major), Acacia Rigidula (moderate) and Adrafinil (moderate).

By severity: 3 major · 110 moderate · 40 minor.

From our pharmacist’s overview on the Lorlatinib page

“Lorlatinib (Lorbrena) treats ALK-positive lung cancer, and keeping its blood level steady is central to keeping the cancer controlled, so I treat this list with genuine vigilance. Nearly all 153 interactions on file run through CYP3A4, the enzyme that clears the drug.”

Reviewed by 2 · Jul 18, 2026

Open the Lorlatinib interaction page

How much people look this up

Where Haronga and Lorlatinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Haronga

Steady interest

#774 of 1,452 supplements looked up here in the last 7 days

29 days ago today

Medication Lorlatinib

Steady interest

#2,010 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?

Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Haronga is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Haronga reference on this page ↓
Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Haronga and Lorlatinib records this page draws on were last updated June 22, 2026.
What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.

Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD, BCPS.

Supplement

About Haronga

What is Haronga?

Indigestion and dyspepsia
Loss of appetite
Digestive complaints
Diarrhea (traditional use)
Wound healing (traditional, topical)

Haronga (Harungana madagascariensis) is an African tree whose bark and leaves have been used traditionally and in some European products for indigestion and digestive complaints. Evidence for its benefits is very limited, and safety information is sparse, so it should be used with caution and under the guidance of a pharmacist or doctor.

Harungana madagascariensis · Hypericaceae · Bark and leaves · Capsules, tablets, dried bark, tea, liquid extracts

An interaction check asks whether these two react with each other — it does not ask whether Haronga is a good idea for someone in your situation. Here is what our Haronga record says about it on its own.

Haronga: dosing

There is no well-established standardized dose for Haronga. Amounts vary between products and traditional preparations.If you use a commercial product, follow the directions on the label and do not exceed the recommended amount.

From our Haronga monograph — the full record covers uses, side effects and every documented interaction.

Read the full Haronga monograph & all interactions

Medication

About Lorlatinib

What Is Lorlatinib Used For?

Brand name: Lorbrena

Lorbrena (lorlatinib) is used to treat adults with metastatic non-small cell lung cancer (NSCLC) — meaning lung cancer that has spread — when lab testing confirms the tumor is ALK-positive (has a specific gene change that drives cancer growth). Patients must be tested with an FDA-approved diagnostic test before starting treatment.

Lorbrena has been studied in patients who have not yet received treatment for advanced disease, as well as in patients whose cancer progressed on other ALK-targeting medicines.

Most-Reported Side Effects for Lorlatinib

From FAERS, the FDA’s public side-effect reporting system (6,977 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Neoplasm progression 621 reports

Hallucination 404 reports

Weight increased 399 reports

Blood cholesterol increased 348 reports

Dyspnea 270 reports

See full Lorlatinib drug information

Keep checking

Other Drugs & Haronga

Browse every other medication we’ve checked against Haronga — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major

0Moderate

0Minor

2,829No known interaction

2,829 No interaction

No interaction 2,829 drugs checked — show the list

We also checked Haronga against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,829 medications checked with no known interaction — see the full Haronga list.

See the full Haronga interactions page

See every supplement checked against Lorlatinib, ranked by severity

Evidence & sources

Haronga References

The 2 sources that drive our Haronga monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Haronga is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.

Dietary Supplements: What You Need to Know — NIH Office of Dietary Supplements Source
Herbs at a Glance — NIH National Center for Complementary and Integrative Health Source

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Haronga and Lorlatinib Together: Common Questions

Is it safe to take Haronga with Lorlatinib?

We do not list a known interaction between Haronga and Lorlatinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.

Does Lorlatinib interact with any supplements?

Yes. Lorlatinib has documented interactions with 153 supplements in our database — Haronga is not one of them. The Lorlatinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

Haronga monograph Uses, safety profile, and every drug interaction in one place Lorlatinib drug information The full plain-English guide to this medication Lorlatinib supplement interactions Every supplement checked against Lorlatinib, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 2 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Lorlatinib and Haronga?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.